TheraSphere (yttrium 90 microspheres) / Boston Scientific  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TheraSphere (yttrium 90 microspheres) / Boston Scientific
2009-016475-29: Treatment of advanced hepatocellular carcinoma (HCC) with portal vein thrombosis by hepatic intra-arterial injection of microspheres loaded with Yttrium-90 (Thera-Sphere)

Ongoing
3
50
Europe
Suspension for injection, TheraSphere
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
advanced hepatocellular carcinoma (HCC) with portal vein thrombosis
 
 
NCT05016245: MANDARIN (S6371)

Recruiting
3
90
RoW
TheraSphere™ Yttrium-90 Glass Microspheres, conventional Transarterial Chemoembolization(cTACE)
Boston Scientific Corporation
Inoperable Hepatocellular Carcinoma
06/25
10/26

Download Options